Experience
Duchesnay Inc.
Actavis Laboratories FL, Inc.
Represented Duchesnay in ANDA litigation in the District of Delaware against multiple generic drug manufacturers seeking to make a generic version of Bonjesta® (doxylaine succinate and phyridoxine hydrochloride) for the treatment of nausea and vomiting in pregnancy.
Duchesnay Inc. v. Actavis Laboratories FL, Inc., 1:18-cv-01895, D. Del., Judges Andrews, Fallon
Eli Lilly and Company v. Actavis Labs. UT Inc.
Eli Lilly and Company
Finnegan secures 10 years of patent protection for Relistor®
Valeant; Salix; Progenics
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
AbbVie Inc.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.